Ignaseclant, NMD Pharma’s experimental oral therapy, may help improve muscle strength and motor function in people with Charcot-Marie-Tooth disease (CMT) by making muscles respond better to weaker nerve signals. That’s according to top-line data from the Phase 2a SYNAPSE-CMT trial (NCT06482437), which also showed consistency in…
Adults with Charcot-Marie-Tooth disease (CMT) say physical symptoms, especially fatigue, along with challenges related to grocery shopping and limited lifestyle-focused guidance from healthcare professionals, can make healthy eating difficult. That’s according to a recent study that also identified factors that helped patients maintain healthier eating habits. These included recognizing…
Becoming educated and informed about Charcot-Marie-Tooth disease is a good first step. Here you’ll find general information about the disease, including diagnosis, symptoms, and causes.
It helps to know others have been where you are now. Here’s a collection of our columnists’ words of wisdom to help you along on your CMT journey.
There is no cure for CMT yet, but here you can find more information about current therapeutic approaches, as well as experimental treatments that are in the pipeline.
Get regular updates to your inbox.
